Drug intelligence / Profile preview

ARNT siRNA

Development stage
Unknown
Lead developer
Thermo Fisher Scientific
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

ARNT siRNA is a double-stranded RNA molecule designed to silence the expression of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) gene, also known as HIF-1β, through the RNA interference (RNAi) pathway. ARNT is a critical bHLH-PAS transcription factor that serves as a common obligate heterodimerization partner for several other proteins, most notably the Hypoxia-Inducible Factor 1-alpha (HIF-1α) and the Aryl Hydrocarbon Receptor (AhR). By knocking down ARNT levels, this siRNA effectively disrupts the formation of functional HIF-1 and AhR transcriptional complexes, thereby inhibiting the cellular response to hypoxia (including angiogenesis and glycolysis) and the response to environmental toxins or xenobiotics. While primarily utilized as a high-precision research tool in molecular biology and oncology to study gene regulation and tumor microenvironment dynamics, ARNT remains a target of interest for therapeutic development in solid tumors where hypoxia-driven pathways promote progression and resistance.

Other names
HIF-1 beta siRNAHIF1 beta siRNAHIF 1 beta siRNAAryl hydrocarbon receptor nuclear translocator siRNA
02

Targets

AHR (Aryl hydrocarbon receptor)ARNT (Aryl hydrocarbon receptor nuclear translocator)Innate immune RNA sensors

Beyond the preview

Go deeper on ARNT siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARNT siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call